Transforming brain monitoring by non-invasive technologies
Biosignal
Decision support
Artificial intelligence methods enable us to aid acute diagnostics and patient monitoring, empowering clinicians with actionable insights. The classifier we developed allows a clear assessment of intracranial pressure (ICP) in severe traumatic brain injury (TBI). The clinical trial TTUS in TBI® is currently conducted in 13 hospitals in Germany.
Our non-invasive Technology
“The non-invasive technology of Sonovum offers completely new opportunities to better detect, monitor and thus better treat a broad spectrum of neurological acute diseases in the future.”
Prof. Dr. Andreas Hetzel, medical director, neurology, Schwarzwaldkliniken Bad Krozingen
Multimodal diagnostics
Therapy Recommendations
Our vision extends beyond diagnostics to personalized therapy recommendations accessible anytime, anywhere. Leveraging AI-driven cohort analyses, we aim to deliver tailored therapy adjustments for enhanced clinical outcomes in the future.